Spatial patterns in discordant diagnostic test results for chagas disease: Links to transmission hotspots

Clinical Infectious Diseases

Volumn 48, Issue 8, 2009, Pages 1104-1106

  Levy, Michael Z ^a,d,j   Bowman, Natalie M ^b,h   Kawai, Vivian ^h   Plotkin, Joshua B ^d   Waller, Lance A ^e   Cabrera, Lilia ^h   Steurer, Frank ^f   Seitz, Amy E ^f   Pinedo Cancino, Viviana V ^h   Carpio, Juan Geny Cornejo Del ⁱ   Benzaquen, Eleazar Cordova ⁱ   McKenzie, F Ellis ^a   Maguire, James H ^g   Gilman, Robert H ^c,h   Bern, Caryn ^f  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e EMORY UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h ASOCIACIÓN BENÉFICA PRISMA   (Peru)

ⁱ Dirección Regional del Ministerio de Salud   (Peru)

^j NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PERU; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SERODIAGNOSIS; TRYPANOSOMA CRUZI;

EID: 63649103891     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597464     Document Type: Article

References (12)

1. World Health Organization Expert Committee. Control of Chagas disease. WHO technical report series number 905. Brasilia, Brazil: World Health Organization, 2000.
2. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am J Trop Med Hyg 1998; 59: 526-9.
3. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007;298:2171-81.
4. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA. Serologic testing for Trypanosoma cruzi: comparison of radioim-munoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme- linked immunosorbent assay kits. J Clin Microbiol 2000;38:639-42.
5. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007; 14:1045-9.
6. Levy MZ, Kawai V, Bowman NM, et al. Targeted screening strategies to detect Trypanosoma cruzi infection in children. PLoS Negl Trop Dis 2007;l:el03.
7. Gurtler RE, Chuit R, Cecere MC, Castanera MB, Cohen JE, Segura EL. Household prevalence of seropositivity for Trypanosoma cruzi in three rural villages in northwest Argentina: environmental, demographic, and entomologic associations. Am J Trop Med Hyg 1998;59:741-9.
8. Anez N, Crisante G, Rojas A, et al. Detection and significance of in-apparent infection in Chagas disease in western Venezuela. Am J Trop Med Hyg 2001;65:227-32.
9. Bowman NM, Kawai V, Levy MZ, et al. Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis 2008;46: 1822-8.
10. Vallejo GA, Guhl F, Schaub GA. Triatominae-Trypanosoma cruzi/T. rangeli: Vector-parasite interactions. Acta Trop 2008.
11. Waller LA, Gotway CA. Applied spatial statistics for public health data. Hoboken, NJ: John Wiley & Sons, 2004.
12. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gurtler RE. The challenges of Chagas disease-grim outlook or glimmer of hope. PLoS Med 2007;4:e332.